BVF PARTNERS L P/IL Insider Trading $RAIN Rain Therapeutics Inc.
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in Rain Therapeutics Inc.
Trading Symbol: RAINIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: Director
Holdings: 761,537 shares
Latest Transaction: May 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in Rain Therapeutics Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 17 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | P | 14.26 | 3,474 | 49,544 | 91,700 | 88.2 K to 91.7 K (+3.94 %) |
May 17 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | P | 14.26 | 22,721 | 324,036 | 555,105 | 532.4 K to 555.1 K (+4.27 %) |
May 17 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | P | 14.26 | 31,805 | 453,587 | 761,537 | 729.7 K to 761.5 K (+4.36 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 134,515 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 152,176 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 17,390 | 0 | 152,176 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 837,397 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 553,359 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 84,350 | 0 | 553,359 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 1,068,554 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 832,261 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 115,293 | 0 | 832,261 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 134,515 | 0 | 286,691 | 152.2 K to 286.7 K (+88.39 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 152,176 | 0 | 152,176 | 0 to 152.2 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 14.90 | 1,747 | 26,032 | 88,226 | 86.5 K to 88.2 K (+2.02 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 15.93 | 6,141 | 97,817 | 86,479 | 80.3 K to 86.5 K (+7.64 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 17.00 | 62,948 | 1,070,116 | 80,338 | 17.4 K to 80.3 K (+361.98 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 17,390 | 0 | 17,390 | 0 to 17.4 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 837,397 | 0 | 1,390,756 | 553.4 K to 1.4 M (+151.33 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 553,359 | 0 | 553,359 | 0 to 553.4 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 14.90 | 10,876 | 162,062 | 532,384 | 521.5 K to 532.4 K (+2.09 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 15.93 | 38,858 | 618,950 | 521,508 | 482.7 K to 521.5 K (+8.05 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 17.00 | 398,300 | 6,771,100 | 482,650 | 84.4 K to 482.7 K (+472.20 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 134,515 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 84,350 | 0 | 84,350 | 0 to 84.4 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 152,176 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 1,068,554 | 0 | 1,900,815 | 832.3 K to 1.9 M (+128.39 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 17,390 | 0 | 152,176 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 832,261 | 0 | 832,261 | 0 to 832.3 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 837,397 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 14.90 | 14,790 | 220,384 | 729,732 | 714.9 K to 729.7 K (+2.07 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 553,359 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 15.93 | 53,303 | 849,037 | 714,942 | 661.6 K to 714.9 K (+8.06 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 84,350 | 0 | 553,359 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 17.00 | 546,346 | 9,287,882 | 661,639 | 115.3 K to 661.6 K (+473.88 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 1,068,554 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 115,293 | 0 | 115,293 | 0 to 115.3 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 832,261 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 115,293 | 0 | 832,261 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 134,515 | 0 | 286,691 | 152.2 K to 286.7 K (+88.39 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 152,176 | 0 | 152,176 | 0 to 152.2 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 14.90 | 1,747 | 26,032 | 88,226 | 86.5 K to 88.2 K (+2.02 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 15.93 | 6,141 | 97,817 | 86,479 | 80.3 K to 86.5 K (+7.64 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 17.00 | 62,948 | 1,070,116 | 80,338 | 17.4 K to 80.3 K (+361.98 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 17,390 | 0 | 17,390 | 0 to 17.4 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 837,397 | 0 | 1,390,756 | 553.4 K to 1.4 M (+151.33 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 553,359 | 0 | 553,359 | 0 to 553.4 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 14.90 | 10,876 | 162,062 | 532,384 | 521.5 K to 532.4 K (+2.09 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 15.93 | 38,858 | 618,950 | 521,508 | 482.7 K to 521.5 K (+8.05 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 17.00 | 398,300 | 6,771,100 | 482,650 | 84.4 K to 482.7 K (+472.20 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 84,350 | 0 | 84,350 | 0 to 84.4 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 1,068,554 | 0 | 1,900,815 | 832.3 K to 1.9 M (+128.39 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 832,261 | 0 | 832,261 | 0 to 832.3 K |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 14.90 | 14,790 | 220,384 | 729,732 | 714.9 K to 729.7 K (+2.07 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 15.93 | 53,303 | 849,037 | 714,942 | 661.6 K to 714.9 K (+8.06 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Grant | A | 17.00 | 546,346 | 9,287,882 | 661,639 | 115.3 K to 661.6 K (+473.88 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 115,293 | 0 | 115,293 | 0 to 115.3 K |
Page: 1